New drug MH-001 put to the test in healthy humans for first time
NCT ID NCT06780254
First seen Mar 07, 2026 · Last updated May 13, 2026 · Updated 10 times
Summary
This early-stage study tested the safety of a new drug, MH-001, in 58 healthy adults. Participants received either single or multiple doses of the drug or a placebo. The main goal was to check for side effects and measure how the drug moves through the body. No treatment benefit was expected, as this was a first-in-human safety trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Syneos Health clinic
Québec, Quebec, G1P 0A2, Canada
Conditions
Explore the condition pages connected to this study.